Tartu Biotechnology Park in cooperation with Association of the Latvian Chemical and Pharmaceutical Industry (LAKIFA), PharmIdea and TBD-Biodiscovery is organising a collaboration and matchmaking event for introduction, promotion and demonstration of collaboration between Estonian and Latvian life science sectors.
Date: April 10th, 2019 at 10.30-14.00
Venue: LAKIFA, Address: 93-27 Dzirnavu Street, Riga, LV-1011
11.00-11.10 Welcome by Vitālijs Skrīvelis, Chairman of the Board, LAKIFA, PharmIdea, Ltd
11.10-11.40 Overview of the life science sector in Latvia. Raina Dūrēja Dombrovska, CEO, LAKIFA
11.40-12.10 Overview of the life science sector in Estonia. Sven Parkel, CEO, Tartu Biotechnology Park
12.10-13.00 PET-Diagnostics. Interreg Est-Lat Programme SME cooperation between PharmIdea and TBD—Biodiscovery. Olga Tšubrik, Member of the Board, TBD-Biodiscovery, Ltd
13.00-13.15 EstLat BioBoost. Introduction to the programme of the project: Boosting cross border entrepreneurial collaboration in life sciences and biotechnology between Latvia and Estonia. Mariann Nõlvak, Program Manager, Tartu Biotechnology Park
REGISTRATION here: https://goo.gl/forms/bZM03UmkNadePwGo2
More information: Mariann Nõlvak, Tartu Biotechnology Park, tel.: +372 7 383 053 or e-mail:
Event is organized within project PET-Diagnostics and in collaboration with EstLat BioBoost. PET-Diagnostics and EstLat BioBoost are implemented and co-financed with the support of the Interreg Estonia-Latvia cross-border cooperation programme https://estlat.eu/en/.
The Project partners TBD-Biodiscovery and PharmIdea have acquired all the competence and experience necessary to enter the PET diagnostic market: production of active ingredients and final dosage drug forms. Both partners are business-driven enterprises with a mission, focusing on both rewarding sales to the customers and making the product available for end-users — oncology and neurology patients in Estonia and Latvia.
The main objective of the Project is to develop a PET-product used in Positron emission tomography-computer tomography (PET-CT) for cancer, Alzheimer or Parkinson diagnostics.
About EstLat BioBoost
EstLat BioBoost promotes cross border entrepreneurial collaboration in life sciences and biotechnology between Latvia and Estonia. The aim of the EstLat BioBoost project is to increase the competitiveness of start-ups and SMEs in the life sciences sector in EE and LV through development of cross-border cooperation and the delivery of training and other support services. Among the support services will be individual coaching/mentoring, and a business mission to Copenhagen to one of the top life sciences business development organisations in Europe.
About the Estonia-Latvia programme
The Estonia-Latvia programme is one of the 60 cross-border cooperation programmes operating along EU internal borders. The programme is funded under the goal of the European Territorial Cooperation, better known as Interreg, and aims at strenghtening cooperation among regions across the borders of Estonia and Latvia. 35 million euros are made available by the European Regional Development Fund for funding cooperation projects among Estonian and Latvian partner organizations.
Estonia-Latvia cross-border cooperation project PET-Diagnostics partners
PharmIdea SIA is Latvia based pharmaceutical company dedicated to the research, development and commercialization of hospital, women health and anti-cancer drugs with main R&D and production competence in sterile formulations.
TBD-Biodiscovery is an innovative Estonian company, founded in 2006 by private capital and contributing to modern healthcare and biotech industry. Our business started with contract services and grew up to custom manufacturing of active pharmaceutical ingredients and building up our own products portfolio. Nowadays TBD-Biodiscovery has wide network of partners worldwide (EU, Switzerland, Israel, US, Russia, South Korea and Japan) and has set up regular production of bioluminescence agents and active pharmaceutical ingredients for both human healthcare and veterinary medicines.
The Association of the Latvian Chemical and Pharmaceutical Industry (LAKIFA) is a non-governmental organisation that since 1995 brings together companies involved in the manufacturing and distribution of the following products: pharmaceuticals, chemicals and chemical agents, rubber compounds, paints, varnishes and construction chemicals, detergents and cleansing products, cosmetics and general consumption product. Also Association includes research and service companies.
Tartu Biotechnology Park (TBP) provides physical infrastructure as well as business development and consultancy services to companies and R&D institutions in the fields of biotechnology, medicine and veterinary medicine. It supports companies in finding cooperation partners and is active in the establishment process of new companies.